She is happy and pain free. Thank you so much VetStem for your part in her recovery!
POWAY, Calif. (PRWEB) October 01, 2019
Cheyenne is a beautiful and strong Quarter Horse and a huge part of her owner’s riding program. Mimi, Cheyenne’s owner, owns and operates Rebel’s Run, which offers riding lessons and trail riding in Afton, Virginia. According to Mimi, Cheyenne was a favorite amongst students and trail riding guests. Mimi describes her as her “go to horse.” Thus, you can imagine the devastation when Cheyenne tore her meniscus.
Mimi stated that Cheyenne was in a lot of pain and one of her veterinarians thought she may need to be euthanized. Fortunately, Mimi and Cheyenne were referred to Dr. Scott Reiners of Mountain View Equine Hospital to potentially receive stem cell therapy. Dr. Reiners is a board-certified veterinary surgeon and has been providing VetStem Cell Therapy since 2007.
Upon examination, Dr. Reiners diagnosed Cheyenne with Osteochondritis Dissecans (OCD) in addition to a torn meniscus and Degenerative Joint Disease (DJD) in her right hind knee. He recommended moving forward with stem cell therapy and began the process by collecting fat from Cheyenne’s tailhead in a minimally invasive surgical procedure. The fat was packaged and shipped overnight to the VetStem laboratory in Poway, California. Once received, VetStem laboratory technicians processed the fat to extract Cheyenne’s stem and regenerative cells to create injectable stem cell doses. Cheyenne’s stem cell injections were shipped to Dr. Reiners who received and injected them within 48 hours of the initial fat collection.
Due to the severity of the injury, Cheyenne required a second treatment with stem cells approximately 4 months after the first round of injections. Fortunately, VetStem had additional stem cell doses stored for Cheyenne so there was no need for a second fat collection procedure.
Mimi reported that the stem cell therapy was successful. She stated, “After meeting with Dr. Reiners, I knew this would work. And boy did it! Cheyenne is 20 years old and fit as a fiddle. It brings tears to my eyes and joy to my heart to see her canter in every night for her feed. She is happy and pain free. Thank you so much VetStem for your part in her recovery!”
Stem cells are regenerative cells that can differentiate into many tissue types, reduce pain and inflammation, help to restore range of motion, and stimulate regeneration of tendon, ligament and joint tissues. In a clinical case series using VetStem Regenerative Cell Therapy in horses with tendon and ligament and joint injuries, it was found that VetStem Regenerative Cell Therapy helped these horses to return to full work or to the activity level that the owner desired.
About Scott Reiners, DVM, DACVS, DACVSMR
Dr. Reiners received his DVM from Kansas State University and completed his surgical residency at Oklahoma State University. He and his wife, Dr. Wynne DiGrassie, started Mountain View Equine Hospital in 2003. Dr. Reiner’s special interests include orthopedic surgery, fracture/tendon repair, laser surgery, shockwave therapy, and sport horse lameness and rehabilitation.
About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-led Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.